For investors who thought 2018 was the best year yet for cannabis stocks, 2019 is already off to an even better start. This will be by far the best year yet for marijuana stocks, thanks to one exceptional catalyst.
Pot stocks in 2019 will be propelled by CBD. That's an acronym for cannabidiol. It's one of the multiple chemical compounds in marijuana. THC is another one. But CBD, unlike THC, doesn't produce feelings of euphoria or being high. It eases disease symptoms, relieves pain, and can be used for wellness applications.
Many people feel that CBD is one of the best pharmaceutical products to be found in nature. And it's likely to power marijuana stocks for years to come.
STAKE YOUR CLAIM: Three pot stocks in particular could be poised for rare, wild gains of up to 1,000%. Click here to learn how you could see a $2 million "pot payday"...
You see, CBD has tremendous potential to treat numerous medical and psychological conditions. These include autism, schizophrenia, and post-traumatic stress disorder (PTSD), just to name a few.
CBD is also quickly growing in popularity as a treatment to aid general health. It relieves arthritis pain. It increases energy. It has multiple applications in treating domestic pets, like cats and dogs. (They get arthritis too.)
So as good as 2018 was for marijuana stocks, 2019 is poised to become even more of a banner year because of CBD.
Legalization Is Becoming Ever More Likely Through the United States
In December 2018, Congress passed the Farm Bill. In effect, it served to normalize CBD across the United States. In the bill, industrial hemp was made legal at the level of U.S. law. Hemp is a form of the cannabis plant. It's also a primary source of CBD.
The federal legality of hemp means that its farmers can now use banking, agricultural insurance, and U.S. grants. They couldn't use them before, for fear that their crops would be deemed illegal and subject to penalties and even prosecution.
For manufacturers and distributors of hemp, it is now completely legal to transport these products, including CBD, all over the United States, including across state boundaries. Previously, they may have been worried, again, about laws and prosecution.
Because of the Farm Bill, retail stores can now offer and sell CBD products without any fear of U.S. government enforcement actions.
The combination of increasing use by consumers and the lifting of any restrictions is going to create a market for which "booming" is an understatement.
CBD and hemp are estimated to be worth roughly $2 billion this year, according to the Brightfield Group, a research company that specializes in marijuana. By 2022, that figure will have increased more than tenfold, to $22 billion.
Money Morning Director of Cannabis Investing Research Greg Miller thinks the outlook is outstanding. He forecasts that 2019 will go down in the history books as "the year of CBD."
There's more...
In the United States, Marijuana Moment followed 915 legislative bills in states and the U.S. Congress in 2018 involving marijuana, medical cannabis, and hemp. A meaningful number proceeded along the legislative track. At least 147 of them were enacted or signed in the District of Columbia and 35 states.
In 2019, state legislators and the U.S. Congress have proposed over 350 pieces of legislation related to pot.
This March, the United Nations plans to de-schedule CBD, whether it comes from cannabis or hemp plants. This will give CBD-related products more impetus about the world.
These events are catalysts. They are snowballing to end up in an unprecedented market.
The more weed is legalized, the more the public will demand. The more the public demands, the more companies will serve that demand. They will provide marijuana and develop new products containing CBD and marijuana.
Companies have been actively strategizing how they can benefit from legalization. They have been waiting for legalization.
As a result, CBD will be made available in an ever-growing number of products. Tinctures to place in tea and other beverages, or to take with a medicine dropper. Energy shots. Nutrition bars. Gummies. Moisturizers for the skin. CBD is likely to be infused into coffee, honey, and even beer.
As acceptance of marijuana and CBD rises, you will also be able to find the products in stores everywhere. Gone are the days when marijuana couldn't be bought legally and related products were found only in head shops.
For investors, the pot market is set to explode. In a short time, it will be mainstream. But before that happens, marijuana investors are facing a once-in-a-lifetime opportunity to profit.
The Top Marijuana Stocks to Watch in February
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
Now, many players in the hemp and marijuana industries have huge potential over the coming years.
But many companies may go downhill, despite an exploding market. There are always winners and losers - just look at the tech industry for how that plays out.
It's important to know the industry, so you know how experts view all the companies involved.
Greg Miller is an expert who is plugged in and reliable.
One of his favorites companies in the cannabis industry has been Canada's Aurora Cannabis Inc. (NYSE: ACB). It still is a favorite.
In December, ACB rolled out an announcement of a deal to supply marijuana products to Mexico, which is yet another country that has legalized medical weed recently.
ACB has also been talking to beverage companies interested in developing drinks infused with marijuana. These include some of the biggest companies in the beverage business, like Molson Coors Brewing Co. (NYSE: TAP) and Coca-Cola Co. (NYSE: KO). KO is interested in entering the cannabis business and has developed a health drink based on CBD.
With enormous catalysts like these, ACB is likely to be a leading marijuana stock in 2019 in terms of performance. Analysts on Wall Street forecast that the share price could skyrocket as much as 80%.
We think even a whopping 80% increase might be underestimating the potential of the marijuana stock market in 2019.
These 3 Stocks Are the Key to 2019's Greatest Profits
The 2018 midterm election was a turning point for the cannabis industry.
We expect nothing short of historic profits by the end of the year.
But not all pot stocks will hand you life-changing wins. In fact, often the companies making headlines are least likely to see the biggest gains.
These three stocks, on the other hand, are flying under the radar... for now. Each of them could see exponential stock price acceleration at any moment, and if you get in before that happens, you could turn a token stake into a lifetime of wealth.
I don't know of any other sector providing anywhere near this level of growth now.